IVUS-XPL: IVUS superior to angiography for guiding DES implantation in long lesions

Original Title: Effect of intravascular ultrasound-guided vs angiography-guided everolimus-eluting stent implantation: the IVUS-XPL randomized clinical trial. Presenter: Hong S-J.

Patients with long coronary lesions have better clinical results after a year of second generation DES implantation when interventions are guided by IVUS, instead of angiography. The benefit was attributed to a lower revascularization rate of ischemia driven target lesions. For the trial, carried out in 20 Korean centers, researchers included 1,400 patients (mean age 64; 69% male) with chest pain or evidence of myocardial ischemia and diffuse long coronary lesions (visually estimatedstent length of  ≥ 28 mm). All patients received the Xience Prime stent (Abbott Vascular) and dual ATP with aspirin and clopidogrel through6 months or more.

In patients randomized to IVUS guided stent implantation online IVUS measurements were used to select stent size and length; adjunct high-pressure dilation was performed at the discretion of the physicians based on IVUS findings.Physicians could perform IVUS at any step of PCI, but IVUS exam was mandatory after PCI.

The average stent length was 39.3 mm. During procedure, patients in the IVUS arm more frequently received adjunct post-dilation (76% vs 57%) and had a larger mean final balloon size (3.14 vs 3.04 mm; P <0.001 for both). As a result, patients who underwent IVUS-guided procedure had a higher minimum lumen diameter (2.64 vs 2.56 mm; P <0.001) and lower diameter stenosis (12.79% vs 13.74%; P = .04) on post-intervention quantitative coronary angiography.

Patients in the IVUS arm required ischemia driven target lesion revascularization 2.5% of times vs. 5% in the control group.

More articles by this author

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...

ACC 2026 | STEMI-Door To Unload: Unloading with Impella before PCI did not reduce infarct size in anterior STEMI

Anterior ST-segment elevation myocardial infarction (STEMI) remains associated with a high incidence of heart failure and mortality, even in the era of early reperfusion....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...